Skip to main content
Figure 2 | World Journal of Surgical Oncology

Figure 2

From: Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone

Figure 2

Sample distribution for high hET1, dCK, and RRM1 expression in unresectable/recurrent biliary tract cancer. The number in each area is the number of samples with high expression of these biomarkers. dCK, deoxycytidine kinase; hENT1, human equilibrative nucleoside transporter; RRM1, ribonucleotide reductase subunit M1.

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us